国产仪器靠什么赢得用户？2025液质联用仪中标年报（上）

Core Viewpoint - The article analyzes how domestic mass spectrometry brands are achieving breakthroughs in structural competition under the banner of "domestic innovation," highlighting brands that are gaining user trust through solid internal capabilities [1][2]. Group 1: Market Trends - In 2025, the winning bid share of domestic LC-MS increased from approximately 11% in 2024 to 17%, indicating a clearer penetration path for domestic brands despite the dominance of imported brands [2]. - The industry is transitioning from expansion to stock competition, with domestic brands focusing on specific application scenarios that are most defined and have the most rigid demand [2]. Group 2: Public Safety Applications - In 2025, domestic brands such as Huayi Ningchuang, Puyutech, and Suzhou Anyi Pu were active in public safety tenders, with Huayi Ningchuang winning the most bids at 16 [6][9]. - Huayi Ningchuang's HTQ-5310 series products have been implemented in multiple regions for wastewater toxic monitoring, achieving a detection limit reduction from 100 ppb to 0.1 ppb for hair drug testing [9]. - Puyutech's SUPEC 5220 system has also won multiple bids for county-level wastewater toxic monitoring projects, enhancing the ability to discover and analyze drug-related clues [9][10]. Group 3: Academic Research - Domestic mass spectrometry manufacturers are increasingly winning bids in key laboratories and major projects in top universities, marking a significant change in a market traditionally dominated by imported brands [12][14]. - Puyutech's EXPEC 5310 has been successfully bid for projects at several universities, including Tianjin University and Southwest University, indicating a growing acceptance of domestic instruments in academic settings [14]. Group 4: Healthcare System - In 2025, several leading medical companies accelerated their investment in the mass spectrometry industry, with domestic brands achieving significant success in tenders within the healthcare system [16][19]. - Kailai Pu won 27 bids across 13 provinces and cities, showcasing strong penetration in hospitals, while Shandong Yingsheng and Hunan Demit also achieved multiple successful bids with their respective products [19]. - The increasing completeness of domestic reagent systems and advantages in cost-effectiveness and localized service are driving the acceleration of domestic liquid chromatography-mass spectrometry (LC-MS) into secondary hospitals and third-party medical laboratories [19][20]. Group 5: Future Outlook - The domestic liquid chromatography-mass spectrometry market in 2025 is characterized by "structural penetration," with advancements in public safety, academic research, and healthcare systems [20]. - The core support for this growth remains the continuous improvement and performance optimization of domestic triple quadrupole technology [20]. - As the industry matures, the focus is shifting from mere technical competition to understanding real user needs and effective market strategies [20].